Trial Comparing Conventional Antibiotic Strategies Versus Regimens Guided by Epidemiological Surveillance in Infected Patients With Cirrhosis (SURVIC_STUDY)

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorEva Bonfill

About this trial

Study to comparing conventrional antibiotic strategies versus regimens guided by epidemiological surveillance in infected patients with cirrhosis.

Eligibility criteria

Qualifiers

Cirrhotic patients with acute decompensation aged ≥18 years.

Proven or suspected bacterial infection requiring antibiotic therapy (diagnosis will be established according to local guidelines, Appendix 1).

Signed informed consent or consent given by their legal representatives or close relatives.

Disqualifiers

Bacterial infection lasting for > 48 hours.

Infection in a critically ill cirrhotic patient (ICU admission). In this population, epidemiological surveillance is standard clinical practice.

Evidence of current locally advanced or metastatic malignancy (patients with hepatocellular carcinoma within the Milan criteria and non-melanocytic skin cancer can be included).

Pregnant and/or breast-feeding woman.

Trial design

Treatments tested in this trial

  • Conventional antibiotic strategies
  • Regimens guided by epidemiological surveillance

Treatment groups

198 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Eva Bonfill

Lead sponsor

Institut d'Investigacions Biomèdiques August Pi i Sunyer

Sponsor institution